I have to say that Pfizer did a fantastic job. Undoubtedly there are a lot of people alive today who otherwise wouldn't be alive if your company hadn't produced the vaccine as quickly as you did. You certainly get kudos for having done that.
You are a company, however, and you have obligations to your shareholders. You also need to recoup the high costs of developing various drugs, so you have to realize a profit in selling, particularly in developed countries. Financially, I think you're going to do pretty well out of this.
What is Pfizer's attitude towards profits in developing countries? Would you consider the possibility of voluntary licensing, or producing and selling vaccines at cost to developing countries?